Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 12/20 | 0.61 |
| ▸ | HRH1 | P35367 | 8/20 | 0.54 |
| ▸ | HTR2C | P28335 | 1/20 | 0.54 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.52 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.52 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.52 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
| ▸ | ANPEP | P15144 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7176437 | 0.86 | HTR2A (0.58) | HTR2AHRH1HTR2CHDAC4HDAC7 | |
| SCHEMBL6514594 | 0.84 | ANPEP (0.59) | HTR2AHRH1HTR2CHDAC4HDAC7 | |
| SCHEMBL7742080 | 0.84 | ANPEP (0.59) | HTR2AHRH1HTR2CHDAC4HDAC7 | |
| SCHEMBL506278 | 0.83 | ACP3 (0.56) | HTR2AMAOAMAOBCYP1A2CYP2D6 | |
| Fluorene SCHEMBL3661672 | 0.80 | MAOA (0.48) | HTR2AHRH1HTR2CHDAC4HDAC7 | |
| Fluorene SCHEMBL7203740 | 0.80 | MAOA (0.48) | HTR2AHRH1HTR2CHDAC4HDAC7 | |
| SCHEMBL2796781 | 0.80 | HTR2A (0.42) | HTR2AHRH1HTR2CHDAC4HDAC7 | |
| SCHEMBL30043804 | 0.80 | HTR2A (0.42) | HTR2AHRH1HTR2CHDAC4HDAC7 | |
| SCHEMBL21847059 | 0.79 | CYP1A2 (0.62) | HTR2AMAOAMAOBCYP1A2CYP2D6 | |
| SCHEMBL3628239 | 0.78 | MAOA (0.60) | HTR2AMAOAMAOBCYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE32943-E | SOLUBILIZING, STABILIZING | HONSHU SEISHI KABUSHIKI KAISHA (JP) | 1989-06-06 | — | — | US | claimed |
| US-4181565-A | Process for cooking lignocellulosic material in the presence of hydroxyanthracenes and derivatives thereof | HONSHU SEISHI KABUSHIKI KAISHA (JP) | 1980-01-01 | — | — | US | claimed |
| US-20230167447-A1 | Compositions for FNIP1/FNIP2 Gene Modulation and Methods Thereof | GENETIC INTELLIGENCE INC (US) | 2023-06-01 | — | — | US | disclosed |
| US-9650357-B2 | Reagent for enhancing generation of chemical species | TOYO GOSEI CO., LTD. (JP) | 2017-05-16 | — | — | US | disclosed |
| US-9618844-B2 | Reagent and composition of resist | TOYO GOSEI CO., LTD. (JP) | 2017-04-11 | — | — | US | disclosed |
| US-9618844-B2 | Reagent and composition of resist | TOYO GOSEI CO., LTD. (JP) | 2017-04-11 | — | — | US | disclosed |
| EP-2970811-B1 | VISCOSITY IMPROVER GRAFTED WITH UNSATURATED ACYLATING AGENT AND A POLYAROMATIC HYDROCARBON | CHEVRON ORONITE CO (US) | 2017-01-25 | — | — | EP | disclosed |
| US-20160194300-A1 | REAGENT FOR ENHANCING GENERATION OF CHEMICAL SPECIES | OSAKA UNIVERSITY (JP) | 2016-07-07 | — | — | US | disclosed |
| US-20160070165-A1 | REAGENT AND COMPOSITION OF RESIST | OSAKA UNIVERSITY (JP) | 2016-03-10 | — | — | US | disclosed |
| US-20160070165-A1 | REAGENT AND COMPOSITION OF RESIST | OSAKA UNIVERSITY (JP) | 2016-03-10 | — | — | US | disclosed |
| EP-2970811-A2 | VISCOSITY IMPROVER GRAFTED WITH UNSATURATED ACYLATING AGENT AND A POLYAROMATIC HYDROCARBON | Chevron Oronite Company LLC (US) | 2016-01-20 | — | — | EP | disclosed |
| WO-2014149086-A2 | VISCOSITY IMPROVER GRAFTED WITH UNSATURATED ACYLATING AGENT AND A POLYAROMATIC HYDROCARBON | CHEVRON ORONITE COMPANY LLC (US) | 2014-09-25 | — | — | WO | disclosed |
| US-20140274842-A1 | VISCOSITY IMPROVER GRAFTED WITH UNSATURATED ACYLATING AGENT AND A POLYAROMATIC HYDROCARBON | CHEVRON ORONITE COMPANY LLC (US) | 2014-09-18 | — | — | US | disclosed |
| US-20130058980-A1 | SMALL MOLECULE INHIBITORS OF PROTEIN KINASES | LEVOLTA PHARMACEUTICALS, INC. | 2013-03-07 | — | — | US | disclosed |
| US-20120322683-A1 | ENZYMATIC SIGNAL GENERATION AND DETECTION OF BINDING COMPLEXES IN STATIONARY FLUIDIC CHIP | INTEL CORPORATION | 2012-12-20 | — | — | US | disclosed |
| US-20060084660-A1 | Psychological disorders; analgesics; Parkinson's disease; antiepileptic agents; irritable bowel disorders; antiarrhythmia agents | NEUROMED TECHNOLOGIES INC. | 2006-04-20 | — | — | US | disclosed |
| CN-1750757-A | Method of deterring birds from plant and structural surfaces | ARKION LIFE SCIENCES LLC (US) | 2006-03-22 | — | — | CN | disclosed |
| CN-1317929-A | Product and method for improving avian health | DCV INC (US) | 2001-10-17 | — | — | CN | disclosed |
| US-RE32943-E | SOLUBILIZING, STABILIZING | HONSHU SEISHI KABUSHIKI KAISHA (JP) | 1989-06-06 | — | — | US | disclosed |
| US-4181565-A | Process for cooking lignocellulosic material in the presence of hydroxyanthracenes and derivatives thereof | HONSHU SEISHI KABUSHIKI KAISHA (JP) | 1980-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160194300-A1 | REAGENT FOR ENHANCING GENERATION OF CHEMICAL SPECIES | CYBB, PPOX, GPX4 | HTR2A 4038/4885HRH1 686/4885HTR2C 4100/4885 |
| US-20230167447-A1 | Compositions for FNIP1/FNIP2 Gene Modulation and Methods Thereof | FNIP1, FN1, TNNC1 | HTR2A 2808/4885HRH1 4800/4885HTR2C 4095/4885 |
| US-20060084660-A1 | Psychological disorders; analgesics; Parkinson's disease; antiepileptic agents; irritable bowel disorders; antiarrhythmia agents | CACNA1D, CACNA1E, CACNA1B | HTR2A 167/4885HRH1 310/4885HTR2C 187/4885 |
| US-20160070165-A1 | REAGENT AND COMPOSITION OF RESIST | ALAD, POLRMT, POLL | HTR2A 4150/4885HRH1 476/4885HTR2C 4035/4885 |
| US-20130058980-A1 | SMALL MOLECULE INHIBITORS OF PROTEIN KINASES | SYK, BTK, LCK | HTR2A 4287/4885HRH1 2108/4885HTR2C 4179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.